#  Precision-Oncology-Matrix

A translational oncology knowledgebase integrating therapeutic biomarkers, resistance mechanisms, pathway biology, and clinical trial matching into a unified computational framework.

---

#  Project Overview

**Precision-Oncology-Matrix** is a structured translational oncology intelligence system that connects:

> Genomic Variants → Biological Mechanisms → Clinical Evidence → Therapeutic Decisions

It integrates curated biomarker knowledge with real-world clinical and trial data to support precision medicine workflows.

---

#  Core Capabilities

- FDA-approved companion diagnostic biomarkers
- Emerging Phase II/III therapeutic targets
- Resistance evolution mechanisms
- Pathway signaling biology
- Variant-to-trial matching engine
- Somatic vs germline interpretation logic
- Clinical decision support via Streamlit app

---

#  System Architecture

## 1.  Data Layer (Curated Knowledgebase)

Located in `/data/`

- approved_targets.csv / json
- emerging_targets.csv / json
- resistance_mechanisms.csv / json
- precision_oncology_master_matrix.csv / json

---

## 2.  Evidence Layer (CIViC Integration)

Located in `/results/`

- curated molecular profile interpretations
- variant-level clinical annotations
- evidence item aggregation

File:
- civic_molecular_profiles.json

---

## 3.  Clinical Trials Layer

Real-world trial matching using ClinicalTrials.gov API:

- KRAS G12C, EGFR, ESR1-based matching
- Phase II/III enrichment filtering
- recruitment status tracking

Files:
- real_kras_trials.json
- matched_trials_report.json

---

## 4.  Backend Engine (Scripts)

Located in `/scripts/`

- variant_to_trial_engine.py
- integrates CIViC + trials + master matrix
- generates unified patient-level reports

---

## 5.  Streamlit Application

Located in `/app/app.py`

Interactive clinical decision support system:

- Gene/variant input
- CIViC evidence lookup
- Clinical trial matching
- Real-time interpretation dashboard

---

## 6.  Visualization Layer

Located in `/figures/`

- system architecture diagram
- translational oncology workflow map

---

#  Variant-to-Insight Pipeline

```
Genomic Variant
↓
CIViC Evidence Mapping
↓
Molecular Profile Interpretation
↓
Clinical Trial Matching
↓
Therapeutic Contextualization
↓
Clinical Report Generation

```
---

#  Somatic vs Germline Interpretation Framework

Key analytical module addressing variant classification ambiguity:

- High VAF germline-like signals (e.g., ATM, BRCA2)
- Loss of heterozygosity (LOH) detection logic
- Population frequency filtering (gnomAD-style reasoning)
- Tumor-only sequencing interpretation challenges

---

#  Resistance Biology Coverage

The system models key cancer resistance evolution mechanisms:

- EGFR C797S (3rd-gen TKI resistance)
- T790M gatekeeper mutation
- MET amplification bypass signaling
- ESR1 ligand-binding domain mutations (Y537S, D538G)
- KRAS pathway reactivation
- ALK solvent-front mutations
- BRAF pathway reactivation
- Small-cell lineage transformation

Each includes:
- molecular mechanism
- pathway disruption logic
- therapeutic escape strategy
- next-generation inhibitor rationale

---

#  Pathway Biology Case Studies

##  Case Study 1: BRAF V600E – MAPK Pathway

- Constitutive activation of MAPK signaling
- Drives melanoma, colorectal, thyroid cancers
- Treated with Dabrafenib + Trametinib
- Combination therapy prevents pathway reactivation

---

##  Case Study 2: PI3K/AKT/mTOR Pathway

- Driven by PTEN loss or AKT1 E17K mutation
- Constitutive survival signaling via mTORC1
- Targeted by Capivasertib / PI3K inhibitors
- Feedback resistance via MAPK activation

---

##  Case Study 3: EGFR Resistance Evolution

- Primary mutations: Exon 19 deletion, L858R
- First-line TKIs: Erlotinib, Gefitinib
- Resistance evolution:
  - T790M (gatekeeper mutation)
  - C797S (3rd-gen TKI resistance)

- Bypass mechanisms:
  - MET amplification
  - HER2 activation
  - KRAS reactivation
  - lineage transformation

- Next-generation strategies:
  - allosteric EGFR inhibitors
  - combination therapy approaches

---

#  Outputs Generated

- Precision oncology knowledge matrices (CSV/JSON)
- CIViC-derived molecular interpretation reports
- Clinical trial matching outputs
- Resistance mechanism atlases
- Streamlit interactive dashboard
- Architecture visualization diagrams

---

#  Deployment

The Streamlit application (https://precision-oncology-matrix.streamlit.app/) enables:

- Mutation input analysis
- Real-time clinical annotation
- Trial matching engine
- Exportable clinical reports

---

#  Scientific & Clinical Value

This project demonstrates:

- Translational bioinformatics reasoning
- Clinical variant interpretation logic
- Multi-database integration (CIViC + ClinicalTrials)
- Oncology pathway modeling
- End-to-end computational medicine pipeline design

---

#  Future Enhancements

- VCF file ingestion pipeline
- Automated tumor board report generation (PDF)
- Multi-patient cohort analytics
- AI-based therapy ranking model
- Real-time oncology knowledge graph expansion

---

#  Summary

Precision-Oncology-Matrix is a computational system that connects:

> Genomics → Evidence → Clinical Trials → Therapy Strategy

into a unified precision oncology intelligence framework.

---
